Effects of a long-term treatment with an antioxidant pyridoindole on vascular responsiveness in diabetes-induced aging rats

Current Aging Science

Volumn 4, Issue 2, 2011, Pages 150-157

  Ceylan Isik, Asli F ^a,b   Ari, Nuray ^a   Stefek, Milan ^c   Sotnikova, Ruzena ^c   Ozansoy, Gülgün ^a   Horakova, Lubica ^c   Karasu, Çimen ^d  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d GAZI UNIVERSITY   (Turkey)

Author keywords

Aged rat; Antioxidants; Calcium; Diabetes; Pyridoindole; Vascular

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ACETYLCHOLINE; CALCIUM ION; CYCLOPIAZONIC ACID; PHENYLEPHRINE; STOBADINE; THAPSIGARGIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMETRY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; HYPERGLYCEMIA; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; VASODILATATION; WEIGHT GAIN;

EID: 79954486205     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811104020150     Document Type: Article

References (42)

1. Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men? Endocrine 2004; 25: 73-83.
2. Bell DS. Hypertension and diabetes: a toxic combination. Endocr Pract 2008; 14: 1031-9.
3. Fleischhacker E, Esenabhalu VE, Spitaler M, Holzmann S, Skrabal F, Koidl B, et al. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes 1999; 48: 1323-30.
4. Koçak G, Aktan F, Canbolat O, Ozoǧul C, Elbeg S, Yildizoglu-Ari N, et al. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab 2000; 13: 308-18.
5. Koçak G, Karasu C. Elimination of *O(2)(-)/H(2)O(2) by alphalipoic acid mediates the recovery of basal EDRF/NO availability and the reversal of superoxide dismutase-induced relaxation in diabetic rat aorta. Diabetes Obes Metab 2002; 4: 69-74.
6. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009; 53: S35-42.
7. Goncharova ND, Marenin VY, Bogatyrenko TN. Stress, aging and reliability of antioxidant enzyme defense. Curr Aging Sci 2008; 1: 22-9.
8. Potenza MA, Gagliardi S, Nacci C, Carratu' MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 2009; 16: 94-112.
9. Horakova L, Stolc S. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen Pharmacol 1998; 30: 627-38.
10. Stefek M, Sotnikova R, Okruhlicova L, Volkovova K, Kucharska J, Gajdosik A, et al. Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol 2000; 37: 111-7.
11. Pekiner B, Ulusu NN, Das-Evcimen N, Sahilli M, Aktan F, Stefek M, et al. Antioxidants in Diabetes-Induced Complications Study Group. In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca2+-ATPase activity in heart and liver of streptozotocindiabetic rats: comparison with vitamin E. Biochim Biophys Acta 2002; 1588: 71-8.
12. Stefek M, Gajdosik A, Tribulova N, Navarova J, Volkovova K, Weismann P, et al. The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats. Methods Find Exp Clin Pharmacol 2002; 24: 565-71.
13. Yulek F, Or M, Ozoǧul C, Isik AC, Ari N, Stefek M, et al. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stres. Arch Med Res 2007; 38: 503-11.
14. Cumaoglu A, Cevik C, Rackova L, Ari N, Karasu C. Effects of antioxidant stobadine on protein carbonylation, advanced oxidation protein products and reductive capacity of liver in streptozotocindiabetic rats: role of oxidative/nitrosative stress. Biofactors 2007; 30: 171-8.
15. Sotnikova R, Stefek M, Okruhlicova L, Navarova J, Bauer V, Gajdosik A, et al. Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocindiabetic rats. Methods Find Exp Clin Pharmacol 2001; 23: 121-9.
16. Sotnikova R, Stefek M, Okruhlicova L, Navarova J, Bauer V, Gajdosik A, et al. Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocindiabetic rats. Methods Find Exp Clin Pharmacol 2001; 23: 121-9.
17. Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, Ari N, et al. Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem Res 2003; 28: 815-23.
18. Sotnikova R, Skalska S, Okruhlicova L, Navarova J, Kyselova Z, Zurova J, et al. Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes. Gen Physiol Biophys 2006; 25: 289-302.
19. Gunes A, Ceylan A, Sarioglu Y, Stefek M, Bauer V, Karasu C. The Antioxidants in Diabetes-induced Complications (ADIC) Study Group. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants. Fundam Clin Pharmacol 2006; 19: 73-9.
20. Guz G, Demirogullari B, Ulusu NN, Dogu C, Demirtola A, Kavutcu M, et al. Stobadine protects rat kidney against ischaemia/ reperfusion injury. Clin Exp Pharmacol Physiol 2007; 34: 210-6.
21. Nosál'ová V, Navarová J, Mihalová D, Sotníková R. Mesenteric ischemia/reperfusion-induced intestinal and vascular damage: effect of stobadine. Methods Find Exp Clin Pharmacol 2007; 29: 39-45.
22. Bunag RD. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 1973; 34: 279-82.
23. Huang Y, Yao X, Lau C, Chan FL, Chan NW, Cheng Y, et al. Role of endothelium in thapsigargin-induced arterial responses in rat aorta. Eur J Pharmacol 2000; 24: 1-9.
24. Weber LP, Chow WL, Abebe W, MacLeod KM. Enhanced contractile responses of arteries from streptozotocin diabetic rats to sodium fluoride. Br J Pharmacol 1996; 118: 115-22.
25. Wei H, Xie Z. Anesthesia, calcium homeostasis and Alzheimer's disease. Curr Alzheimer Res 2009; 6: 30-5.
26. Zhu BH, Guan YY, Min J, He H. Contractile responses of diabetic rat aorta to phenylephrine at different stages of diabetic duration. Acta Pharmacol Sin 2001; 22: 445-9.
27. Yoo HJ, Kozaki K, Akishita M, Watanabe M, Eto M, Nagano K, et al. Augmented Ca2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats. Atherosclerosis 1997; 131: 167-75.
28. Ma L, Zhu B, Chen X, Liu J, Guan Y, Ren J. Abnormalities of sarcoplasmic reticulum Ca2+ mobilization in aortic smooth muscle cells from streptozotocin-induced diabetic rats. Clin Exp Pharmacol Physiol 2008; 35: 568-73.
29. Yamaguchi T, Sugimoto T. Calcium homeostasis and diabetes mellitus. Clin Calcium 2006; 16: 1270-5.
30. Fellner SK, Arendshorst WJ. Angiotensin II Ca2+ signaling in rat afferent arterioles: Stimulation of cyclic ADP ribose and IP3 pathways. Am J Physiol Renal Physiol 2005; 288: F785-91.
31. Zhou JG, Qiu QY, Zhang Z, Liu YJ, Guan YY. Evidence for capacitative and non-capacitative Ca2+ entry pathways coexist in A10 vascular smooth muscle cells. Life Sci 2006; 78: 1558-63.
32. Curtis TM, Major EH, Trimble ER, Scholfield CN. Diabetesinduced activation of protein kinase C inhibits store-operated Ca2+ uptake in rat retinal microvascular smooth muscle. Diabetologia 2003; 46: 1252-9.
33. Gonzalez De La Fuente P, Savineau JP, Marthan R. Control of pulmonary vascular smooth muscle tone by sarcoplasmic reticulum Ca2+ pump blockers: Thapsigargin and cyclopiazonic acid. Pflügers Arch 1995; 429: 617-24.
34. Tostes RC, Wilde DW, Bendhack LM, Webb RC. The effects of cyclopiazonic acid on intracellular Ca2+ in aortic smooth muscle cells from DOCA-hypertensive rats. Braz J Med Biol Res 1997; 30: 257-67.
35. Kaplan P, Babusikova E, Lehotsky J, Dobrota D. Free radicalinduced protein modification and inhibition of Ca2+-ATPase of cardiac sarcoplasmic reticulum. Mol Cell Biochem 2003; 248: 41-7.
36. Okon EB, Golbabaie A, Breemen C. Paracrine effects of endothelial cells in a diabetic mouse model: capacitative calcium entry stimulated thromboxane release. Horm Metab Res 2008; 40: 645-50.
37. Altan VM, Karasu C, Ozüari A. The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta. Pharmacol Biochem Behav 1989; 33: 519-22.
38. Karasu C, Altan VM. The role of endothelial cells on the alterations in vascular reactivity induced by insulin-dependent diabetes mellitus: effects of insulin treatment. Gen Pharmacol 1993; 24: 743-55.
39. Triggle CR, Ding H, Anderson TJ, Pannirselvam M. The endothelium in health and disease: a discussion of the contribution of nonnitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. Mol Cell Biochem 2004; 263: 21-7.
40. Moncada S, Palmer RMJ, Higgs EAA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
41. Reed PW, Lardy HA. A23187: a divalent cation ionophore. J Biol Chem 1972; 247: 6970-7.
42. Hutcheson IR, Griffith TM. Central role of intracellular calcium stores in acute flow- and agonist-evoked endothelial nitric oxide release. Br J Pharmacol 1997; 122: 117-25.